LGALS7 and cancer: Although several strategies were developed to knockout galectin-7 or suppress its translation, we believe the field of cellular pathophysiology would benefit from small-molecule inhibitors which can be administered to evaluate its effect on cellular disorders and even diseases such as cancer.